1. Structural Basis for DNA Gyrase Interaction with Coumermycin A1
- Author
-
Alastair G. McEwen, Yassmine Chebaro, Valérie Lamour, Arnaud Vanden Broeck, Noëlle Potier, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Structural Biology and Genomics Platform [Illkirch], Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Substances naturelles/chimie moléculaire, and Université Louis Pasteur - Strasbourg I-Ecole européenne de chimie, polymères et matériaux [Strasbourg]-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Aminocoumarins ,Stereochemistry ,Isomerase ,Molecular Dynamics Simulation ,01 natural sciences ,DNA gyrase ,03 medical and health sciences ,Adenosine Triphosphate ,Drug Discovery ,Escherichia coli ,Protein Structure, Quaternary ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,0303 health sciences ,Binding Sites ,Chemistry ,Thermus thermophilus ,Hydrogen Bonding ,SUPERFAMILY ,Coumermycin A1 ,0104 chemical sciences ,3. Good health ,Protein Subunits ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM] ,010404 medicinal & biomolecular chemistry ,DNA Gyrase ,Molecular Medicine ,Dimerization ,Bacterial dna - Abstract
Coumermycin A1 is a natural aminocoumarin that inhibits bacterial DNA gyrase, a member of the GHKL proteins superfamily. We report here the first cocrystal structures of gyrase B bound to coumermycin A1, revealing that one coumermycin A1 molecule traps simultaneously two ATP-binding sites. The inhibited dimers from different species adopt distinct sequence-dependent conformations, alternative to the ATP-bound form. These structures provide a basis for the rational development of coumermycin A1 derivatives for antibiotherapy and biotechnology applications.
- Published
- 2019